ECA
FBT icon

Elevated Capital Advisors’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Elevated Capital Advisors’s Portfolio FBT Stock Details FBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$744 Hold
3
– – ﹤0.01% 772
2026
Q1 		$602 Hold
3
– – ﹤0.01% 774
2025
Q4 		$620 Buy
+3
New +$599 ﹤0.01% 747

Other funds holding FBT

First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return
BFG
Berger Financial Group Plymouth, Minnesota $1.96B AUM 20.58% 1-Year Est. Return

Elevated Capital Advisors's FBT Position: Q2 2026 in Review

Elevated Capital Advisors held its First Trust NYSE Arca Biotechnology Index Fund (FBT) position steady in Q2 2026 at 3 shares worth $744. The position accounts for ﹤0.01% of the portfolio, ranked #772.

Elevated Capital Advisors first reported a position in FBT in Q4 2025 and has held it in 3 quarters since. 339 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

  • Elevated Capital Advisors held 3 shares of First Trust NYSE Arca Biotechnology Index Fund worth $744 as of Q2 2026.
  • Elevated Capital Advisors left its First Trust NYSE Arca Biotechnology Index Fund share count unchanged in Q2 2026.
  • First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of Elevated Capital Advisors's portfolio in Q2 2026, its #772 holding.
  • Elevated Capital Advisors first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2025 and has held it in 3 quarters since.
  • 339 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on Elevated Capital Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.